SEC Form 4 · accession 0001415889-16-004934
Echo Therapeutics, Inc. · ECTE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Alan Wayne Schoenbart
Officer — CFO AND SECRETARY
Period of report
Mar 1, 2016
Accepted (ET)
Mar 3, 2016 · 2:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001031927
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2016 | A | 100,000 | $0.00 | A | 102,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options (Right to Buy)F3,F2 | $1.12 | Mar 1, 2016 | A | 150,000 | A | — | Mar 1, 2026 | Common Stock | 150,000 | 50,000 | D |
Explanation of responses
- F1Restricted shares granted pursuant to 2008 Equity Compensation Plan which vests on the 18-month anniversary of the date of grant.
- F21/3 vest immediately, 1/3 vest on the first anniversary of the grant date, and 1/3 vest on the second anniversary of the grant date.
- F3Granted Pursuant to the Echo Therapeutics, Inc. 2008 Equity Compensation Plan.